CD97 was found to be involved in invasiveness and metastasis of prostate cancer, (where it forms heterodimers with the lysophosphatidic acid receptor LPAR1 [49], [50]) and more recently of GBMs [48], [51]. The gene discussed is LPAR1; the disease is prostate carcinoma.